Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Recent studies have demonstrated great therapeutic potential of educating and unleashing our own immune system for cancer treatment. However, there are still major challenges in cancer immunotherapy, including poor immunogenicity of cancer vaccines, off-target side effects of immunotherapeutics, as...
Main Authors: | Yuchen Fan, James J. Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/3/662 |
Similar Items
-
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
by: Wouter W. van Willigen, et al.
Published: (2018-10-01) -
Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01) -
Dendritic Cells and Their Role in Immunotherapy
by: Alycia Gardner, et al.
Published: (2020-05-01) -
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
by: Karim Vermaelen
Published: (2019-01-01) -
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
by: Soledad eMac Keon, et al.
Published: (2015-05-01)